Abstract:Hybrid molecules maintain their stronghold in the drug market, with over 60% of drug candidates in pharmaceutical industries. The substantial expenses for developing and producing biologically privileged drugs are expected to create opportunities for producing hybrid molecule-based drugs. Therefore, we have developed a simple and efficient copper-catalyzed approach for synthesizing a wide range of triazole-linked glycohybrids derived from pyrazolo[1,5- a ]pyrimidines. Employing a microwave-assisted copper-catalyzed approach, we developed a concise route using various 7- O -propargylated pyrazolo[1,5- a ]pyrimidines and 1-azidoglycosides. This strategy afforded a series of twenty-seven glycohybrids up to 98% yield with diverse stereochemistry. All were achieved within a remarkably shortened time frame. Our investigation extends to evaluating the anticancer potential of these synthesized triazole-linked pyrazolo[1,5- a ] pyrimidine-based glycohybrids. In-vitro assays against MCF-7, MDA-MB231, and MDA-MB453 cell lines reveal intriguing findings. ( 2R,3S,4S,5R,6R )-2-(acetoxymethyl)-6-(4-(((5-(4-chlorophenyl)pyrazolo[1,5- a ]pyrimidin-7-yl)oxy)methyl)-1 H -1,2,3-triazol-1-yl)tetrahydro-2 H -pyran-3,4,5-triyl triacetate emerges as a standout with better anticancer activity against MDA-MB231 cells (IC 50 = 29.1 μM), while ( 2R,3R,4S,5R,6R )-2-(acetoxymethyl)-6-(4-(((5-(4-chlorophenyl)pyrazolo[1,5- a ]pyrimidin-7-yl)oxy)methyl)-1 H -1,2,3-triazol-1-yl)tetrahydro-2 H -pyran-3,4,5-triyl triacetate demonstrates the best inhibitory effects against MCF-7 cells (IC 50 = 15.3 μM) in all derived compounds. These results align with our docking analysis and structure–activity relationship (SAR) investigations, further validating the in-vitro outcomes. This work not only underscores the synthetic utility of our devised protocol but also highlights the promising potential of these glycohybrids as candidates for further anticancer therapeutic exploration.

Development in the Synthesis of Bioactive Thiazole-Based Heterocyclic Hybrids Utilizing Phenacyl Bromide

A Multifaceted Scaffold for Building Bioactive Compounds: Phenothiazine

Development of Phenothiazine Hybrids with Potential Medicinal Interest: A Review

1,3,5-Triazine: Recent Development in Synthesis of its Analogs and Biological Profile

Pyrazine and Phenazine Heterocycles: Platforms for Total Synthesis and Drug Discovery

Benzimidazole–Oxadiazole Hybrids—Development in Medicinal Chemistry: An Overview

Innovative Pyrazole Hybrids: A New Era in Drug Discovery and Synthesis

1,2,3-Triazole Hybrids Containing Isatins and Phenolic Moieties: Regioselective Synthesis and Molecular Docking Studies

Synthesis of Structurally Diverse and Biologically Promising Polyheterocycles Involving Benzo[ a ]phenazin-5-ols

Update on Thiopyran Fused Heterocycle Synthesis (2013-2024)

Diaryl Pyrazoline, 1,3,4-Oxadizole, and 1,2,4-Triazole Pharmacophore Hybridization: Design, Synthesis, HDAC Inhibition, and Caspase 3/7 Activation Studies

Copper-catalyzed synthesis of pyrazolo[1,5-a]pyrimidine based triazole-linked glycohybrids: mechanistic insights and bio-applications

Design, synthesis, biological activity, molecular docking and computational studies on novel 1,4-disubstituted-1,2,3-Triazole-Thiosemicarbazone hybrid molecules

Efficient Synthesis of Hybrid Compounds from 1,2,3-Triazoles, Benzimidazole, and Thiazolo[3,2-a]Benzimidazole Through Palladium-Catalyzed Coupling-Heteroannulation Reactions

Greener and Highly Efficient Synthesis, In Silico ADMET and Molecular Docking Studies of Potent Antimicrobial Thiophene Clubbed Pyrazole‐1,2,3‐Triazole Hybrids

Benign Synthesis of Fused-thiazoles with Enone-based Natural Products and Drugs for Lead Discovery

Synthetic Access to Diverse Thiazetidines via One-Pot Microwave Assisted Telescopic Approach and its Interaction with Biomolecules

Synthesis, characterization, molecular docking, antimicrobial and antifungal studies of some novel fused-ring heterocyclic compounds

Synthesis of novel thiazole, pyranothiazole, thiazolo[4,5-b]pyridines and thiazolo[5′,4′:5,6]pyrano[2,3-d]pyrimidine derivatives and incorporating isoindoline-1,3-dione group

Synthesis, molecular docking, QSTR and in‐silico ADME studies of novel 1,3‐thiazolidine‐amide derivatives as hybrid bioactive heterocycles

Sonochemical Synthesis and In Silico Studies of Phthalazine Scaffolds Bearing 1,3,4-Oxadiazolyl-1,2,3-triazoles as Potent Antitubercular Agents